Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
AMIWOK, AMIKACIN WOCKHARDT (Wockhardt Bio Pty Ltd)
Product name
AMIWOK, AMIKACIN WOCKHARDT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
151 working days (255)
Active ingredients
amikacin (as sulfate)
Registration type
New generic medicine
Indication
AMIWOK, AMIKACIN WOCKHARDT (solution for injection) is indicated in the:
- short-term treatment of serious infections caused by susceptible strains of Gram-negative bacteria;
- treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.